aoki2010duration
stool_norovirus
|
norovirus |
stool | symptom onset |
exponential |
7.09 | gc/wet gram |
0.51 |
2.15 |
13 |
57 |
25 |
105.5 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
5.01 | gc/dry gram |
1.04 |
1.33 |
34 |
290 |
98 |
759.5 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.36 | gc/dry gram |
0.83 |
1.33 |
29 |
275 |
95 |
666.9 |
arts2023longitudinal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool | symptom onset |
gamma shifted |
4.14 | gc/dry gram |
0.75 |
1.33 |
28 |
274 |
94 |
669.3 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
4.47 | gc/dry gram |
1.12 |
1.31 |
35 |
297 |
107 |
814.1 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.3 | gc/dry gram |
0.87 |
1.31 |
30 |
282 |
104 |
713.1 |
arts2023longitudinal
stool_SARSCoV2_ORF1a
|
SARS-CoV-2 |
stool | symptom onset |
gamma shifted |
4.25 | gc/dry gram |
0.8 |
1.31 |
29 |
281 |
104 |
724.0 |
atmar2008norwalk
stool_norovirus
|
norovirus |
stool | enrollment |
exponential |
10.82 | gc/dry gram |
0.69 |
7.6 |
16 |
182 |
33 |
412.7 |
atmar2008norwalk
stool_norovirus
|
norovirus |
stool | enrollment |
gamma |
10.35 | gc/dry gram |
0.57 |
7.6 |
16 |
182 |
33 |
381.9 |
berciaud2012adenovirus
stool_gc_wet_gram
|
adenovirus |
stool | treatment |
exponential |
10.05 | gc/wet gram |
0.84 |
3.98 |
4 |
19 |
0 |
65.2 |
biel2000rapid
urine_polyomavirus_dna
|
BK polyomavirus |
urine | treatment |
exponential |
9.37 | gc/mL |
1.56 |
3.32 |
4 |
55 |
10 |
201.1 |
brieu2008human
nasopharyngeal_secretions_bocavirus_viral_load
|
bocavirus |
nasopharyngeal_aspirate | enrollment |
exponential |
4.73 | gc/mL |
0.89 |
1.0 |
6 |
13 |
3 |
52.0 |
brint2017prolonged
nasal_aspirate_respiratory_syncytial_virus_viral_load
|
RSV |
nasopharyngeal_aspirate | symptom onset |
exponential |
6.96 | pfu/mL |
1.16 |
-0.01 |
25 |
212 |
30 |
695.0 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
exponential |
7.2 | gc/mL |
1.0 |
4.0 |
78 |
1278 |
596 |
2386.3 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
gamma |
6.89 | gc/mL |
0.94 |
4.0 |
75 |
1235 |
589 |
2298.9 |
cdc2024nhphrn
NP_SARSCoV2_VL
|
SARS-CoV-2 |
nasopharyngeal_swab | confirmation date |
gamma shifted |
7.11 | gc/mL |
0.94 |
4.0 |
75 |
1265 |
589 |
2528.0 |
chilengi2020pilot
stool_rotavirus_viral_load
|
rotavirus |
stool | vaccination |
exponential |
6.65 | gc/wet gram |
1.07 |
1.59 |
16 |
43 |
8 |
175.2 |
colavita2023kinetics
oropharyngeal_swab_gc_ng
|
mpox |
oropharyngeal_swab | symptom onset |
exponential |
2.12 | gc/ng |
0.66 |
-0.6 |
3 |
9 |
1 |
30.5 |
colavita2023kinetics
saliva_gc_ng
|
mpox |
saliva | symptom onset |
exponential |
3.12 | gc/ng |
0.9 |
-0.6 |
3 |
9 |
1 |
35.8 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose1
|
rotavirus vaccine |
stool | vaccination |
exponential |
9.94 | gc/wet gram |
1.01 |
2.0 |
13 |
80 |
44 |
172.6 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose2
|
rotavirus vaccine |
stool | vaccination |
exponential |
9.0 | gc/wet gram |
0.98 |
2.0 |
12 |
73 |
42 |
148.3 |
cowley2017rotavirus
stool_rotavirus_vaccine_dose3
|
rotavirus vaccine |
stool | vaccination |
exponential |
8.66 | gc/wet gram |
0.93 |
2.0 |
9 |
44 |
22 |
106.1 |
el2011respiratory
respiratory_secretions_RSV_viral_load
|
RSV |
nasopharyngeal_aspirate | enrollment |
exponential |
6.63 | pfu/mL |
0.39 |
0.75 |
8 |
30 |
4 |
60.4 |
engelmann2009adenovirus
serum_adenovirus_viral_load
|
adenovirus |
serum | treatment |
exponential |
3.08 | gc/mL |
1.28 |
2.0 |
8 |
40 |
24 |
102.6 |
engelmann2009adenovirus
serum_adenovirus_viral_load
|
adenovirus |
serum | treatment |
gamma |
3.95 | gc/mL |
0.6 |
2.0 |
7 |
28 |
16 |
73.6 |
enya2023similarities
1_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
gamma |
7.29 | gc/reaction |
0.48 |
1.78 |
20 |
156 |
9 |
329.4 |
enya2023similarities
2_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
exponential |
4.64 | gc/reaction |
1.14 |
2.22 |
20 |
171 |
50 |
513.9 |
enya2023similarities
2_gc_reaction
|
rotavirus vaccine |
stool | vaccination |
gamma shifted |
5.64 | gc/reaction |
0.68 |
2.22 |
20 |
161 |
40 |
439.4 |
fajnzylber2020sars
Nasopharyngeal_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
5.48 | gc/mL |
0.88 |
1.6 |
16 |
39 |
16 |
138.2 |
fajnzylber2020sars
Oropharyngeal_PBS_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
4.99 | gc/mL |
0.34 |
1.6 |
10 |
24 |
5 |
58.3 |
fajnzylber2020sars
Sputum_SARSCoV2_N
|
SARS-CoV-2 |
sputum | symptom onset |
exponential |
7.86 | gc/mL |
0.45 |
1.6 |
15 |
36 |
6 |
106.3 |
falsey2003comparison
nasal_respiratory_syncytial_virus_quant_rt_pcr
|
RSV |
nasal_lavage_fluid | inoculation |
exponential |
1.61 | pfu/mL |
1.75 |
1.0 |
11 |
154 |
83 |
418.2 |
flitter2025oral
stool
|
norovirus |
stool | inoculation |
exponential |
7.81 | gc/wet gram |
1.5 |
5.18 |
94 |
386 |
109 |
1582.0 |
flitter2025oral
stool
|
norovirus |
stool | inoculation |
gamma |
8.16 | gc/wet gram |
0.31 |
5.18 |
86 |
370 |
106 |
678.4 |
fraaij2015viral
particles_ml
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
5.71 | vp/mL |
1.03 |
2.79 |
4 |
14 |
2 |
54.1 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
exponential |
6.42 | gc/mL |
1.08 |
0.26 |
74 |
529 |
0 |
1885.3 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma |
6.3 | gc/mL |
0.94 |
0.26 |
66 |
503 |
0 |
1766.9 |
garciaknight2022infectious
e
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma shifted |
5.89 | gc/mL |
0.9 |
0.26 |
63 |
503 |
0 |
1822.6 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
exponential |
6.41 | gc/mL |
0.95 |
0.26 |
66 |
440 |
2 |
1469.8 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma |
5.9 | gc/mL |
0.82 |
0.26 |
62 |
424 |
2 |
1409.0 |
garciaknight2022infectious
n
|
SARS-CoV-2 |
anterior_nares_swab | symptom onset |
gamma shifted |
5.57 | gc/mL |
0.78 |
0.26 |
58 |
419 |
2 |
1447.8 |
ge2023effect
4800_stool
|
norovirus |
stool | inoculation |
exponential |
9.44 | gc/wet gram |
0.87 |
7.6 |
6 |
105 |
28 |
251.9 |
ge2023effect
4800_stool
|
norovirus |
stool | inoculation |
gamma |
9.78 | gc/wet gram |
0.63 |
7.6 |
6 |
105 |
28 |
195.9 |
ge2023effect
48_stool
|
norovirus |
stool | inoculation |
exponential |
9.47 | gc/wet gram |
1.42 |
7.6 |
7 |
102 |
34 |
309.6 |
ge2023effect
48_stool
|
norovirus |
stool | inoculation |
gamma |
10.25 | gc/wet gram |
0.85 |
7.6 |
7 |
102 |
34 |
229.2 |
ge2023effect
4_8_stool
|
norovirus |
stool | inoculation |
exponential |
8.87 | gc/wet gram |
1.28 |
7.6 |
6 |
75 |
33 |
201.1 |
ge2023effect
4_8_stool
|
norovirus |
stool | inoculation |
gamma |
9.59 | gc/wet gram |
0.69 |
7.6 |
6 |
75 |
33 |
137.5 |
gerna2007human
hospital_admission_rsv
|
RSV |
nasopharyngeal_aspirate | hospital admission |
exponential |
6.37 | gc/mL |
0.0 |
3.0 |
5 |
10 |
0 |
-159.6 |
golantripto2024viral
utm_vp_ml_nasopharyngeal_swab
|
RSV |
nasopharyngeal_swab | hospital admission |
exponential |
5.67 | vp/mL |
0.11 |
2.59 |
12 |
24 |
0 |
13.3 |
golantripto2024viral
vcm_vp_ml_nasopharyngeal_swab
|
RSV |
nasopharyngeal_swab | hospital admission |
exponential |
5.54 | vp/mL |
0.2 |
2.39 |
12 |
24 |
0 |
41.4 |
golantripto2024viral
utm_vp_ml_nasal_lavage_fluid
|
RSV |
nasal_lavage_fluid | hospital admission |
exponential |
7.42 | vp/mL |
0.06 |
4.39 |
12 |
24 |
0 |
-17.3 |
golantripto2024viral
vcm_vp_ml_nasal_lavage_fluid
|
RSV |
nasal_lavage_fluid | hospital admission |
exponential |
7.45 | vp/mL |
0.03 |
4.29 |
12 |
24 |
0 |
-46.7 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
5.63 | gc/mL |
2.65 |
1.5 |
17 |
242 |
96 |
894.1 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma |
6.09 | gc/mL |
1.58 |
1.5 |
16 |
223 |
85 |
701.1 |
hakki2022onset
asymptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma shifted |
6.43 | gc/mL |
1.57 |
1.5 |
16 |
228 |
85 |
748.5 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
exponential |
1.54 | pfu/mL |
1.98 |
0.99 |
14 |
214 |
162 |
376.9 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma |
1.73 | pfu/mL |
1.22 |
0.99 |
12 |
186 |
138 |
290.4 |
hakki2022onset
asymptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | enrollment |
gamma shifted |
1.52 | pfu/mL |
1.21 |
0.99 |
13 |
200 |
150 |
327.8 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
6.4 | gc/mL |
2.42 |
1.82 |
33 |
452 |
105 |
1905.9 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma |
7.95 | gc/mL |
0.85 |
1.9 |
32 |
340 |
56 |
948.4 |
hakki2022onset
symptomatic_PCR
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma shifted |
7.63 | gc/mL |
0.95 |
1.82 |
33 |
403 |
56 |
1256.8 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
2.18 | pfu/mL |
2.06 |
0.99 |
31 |
426 |
248 |
1118.1 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma |
4.08 | pfu/mL |
0.66 |
0.99 |
30 |
322 |
173 |
515.6 |
hakki2022onset
symptomatic_cultivable
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
gamma shifted |
4.08 | pfu/mL |
0.72 |
0.99 |
30 |
349 |
173 |
663.7 |
hanaoka2019infectious
urine_adenovirus_viral_load
|
adenovirus |
urine | symptom onset |
exponential |
8.34 | gc/mL |
0.44 |
2.29 |
21 |
61 |
15 |
143.4 |
hu2013association
oropharyngeal_swab
|
influenza |
oropharyngeal_swab | symptom onset |
exponential |
4.98 | gc/swab |
1.3 |
2.14 |
13 |
133 |
92 |
237.8 |
hu2013association
oropharyngeal_swab
|
influenza |
oropharyngeal_swab | symptom onset |
gamma |
4.83 | gc/swab |
1.26 |
2.14 |
13 |
133 |
92 |
261.1 |
hu2013association
urine
|
influenza |
urine | symptom onset |
exponential |
3.93 | gc/mL |
0.61 |
2.25 |
11 |
76 |
55 |
121.7 |
hu2013association
urine
|
influenza |
urine | symptom onset |
gamma |
3.27 | gc/mL |
0.6 |
2.25 |
11 |
76 |
55 |
143.1 |
hu2013association
stool
|
influenza |
stool | symptom onset |
exponential |
3.51 | gc/wet gram |
1.14 |
2.15 |
11 |
76 |
51 |
160.9 |
hu2013association
stool
|
influenza |
stool | symptom onset |
gamma |
3.68 | gc/wet gram |
1.13 |
2.15 |
11 |
76 |
51 |
181.2 |
huh2019prolonged
sputum_nasopharyngeal_swab
|
adenovirus |
sputum+nasopharyngeal_swab | treatment |
exponential |
8.07 | gc/mL |
0.41 |
3.45 |
5 |
26 |
0 |
49.4 |
iwakiri2009quantitative
stool_SaV
|
sapovirus |
stool | symptom onset |
exponential |
8.7 | gc/wet gram |
0.16 |
5.11 |
17 |
41 |
19 |
52.0 |
kay2011shedding
nasal_lavage_influenza_gc_per_mL
|
influenza |
nasal_lavage_fluid | symptom onset |
exponential |
8.09 | gc/mL |
0.34 |
3.0 |
8 |
37 |
0 |
59.2 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
6.63 | gc/mL |
1.2 |
0.89 |
60 |
795 |
138 |
2515.3 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
6.26 | gc/mL |
0.88 |
0.89 |
59 |
731 |
123 |
2068.8 |
ke2022daily
nasal_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma shifted |
6.57 | gc/mL |
0.89 |
0.89 |
60 |
792 |
135 |
2328.0 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
exponential |
6.34 | gc/mL |
1.46 |
3.06 |
60 |
883 |
216 |
2945.3 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
gamma |
7.09 | gc/mL |
0.76 |
3.06 |
59 |
727 |
163 |
1777.6 |
ke2022daily
saliva_SARSCoV2
|
SARS-CoV-2 |
saliva | symptom onset |
gamma shifted |
7.43 | gc/mL |
0.74 |
3.06 |
60 |
843 |
176 |
2126.1 |
kirby2014disease
stool_norovirus_gc_wet_gram_gi
|
norovirus |
stool | inoculation |
exponential |
5.93 | gc/wet gram |
2.72 |
3.55 |
15 |
121 |
51 |
470.5 |
kirby2014disease
stool_norovirus_gc_wet_gram_gi
|
norovirus |
stool | inoculation |
gamma |
7.67 | gc/wet gram |
1.63 |
3.55 |
15 |
121 |
51 |
390.8 |
kirby2014disease
stool_norovirus_gc_wet_gram_gii
|
norovirus |
stool | inoculation |
exponential |
4.6 | gc/wet gram |
1.9 |
3.25 |
9 |
69 |
32 |
225.6 |
kirby2014disease
stool_norovirus_gc_wet_gram_gii
|
norovirus |
stool | inoculation |
gamma |
5.33 | gc/wet gram |
1.09 |
3.25 |
9 |
69 |
32 |
182.3 |
kirby2016vomiting
emesis_norovirus_GII
|
norovirus |
emesis | symptom onset |
exponential |
3.04 | gc/mL |
0.86 |
-2.37 |
3 |
16 |
1 |
55.0 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
exponential |
3.77 | gc/mL |
1.79 |
2.66 |
67 |
2173 |
1948 |
1495.8 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
gamma |
5.7 | gc/mL |
0.74 |
2.66 |
51 |
1679 |
1525 |
778.2 |
kissler2021viral
AN_OPS_SARSCoV2_viral
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab | confirmation date |
gamma shifted |
5.74 | gc/mL |
0.79 |
2.66 |
60 |
2072 |
1858 |
1130.0 |
kondo2016influenza
nasal_discharge_influenza_gc_per_mL
|
influenza |
nasal_discharge | symptom onset |
exponential |
6.51 | gc/mL |
0.59 |
3.5 |
28 |
84 |
29 |
229.3 |
kondo2016influenza
nasal_discharge_influenza_gc_per_mL
|
influenza |
nasal_discharge | symptom onset |
gamma |
6.13 | gc/mL |
0.27 |
3.5 |
19 |
57 |
19 |
130.7 |
lavezzo2020suppression
RdRp_first_pos
|
SARS-CoV-2 |
oropharyngeal_swab | confirmation date |
exponential |
3.07 | gc/mL |
0.06 |
1.42 |
44 |
88 |
36 |
38.1 |
lavezzo2020suppression
E_first_pos
|
SARS-CoV-2 |
oropharyngeal_swab | confirmation date |
exponential |
4.17 | gc/mL |
2.74 |
0.73 |
40 |
80 |
28 |
423.7 |
lavezzo2020suppression
RdRp_symptom
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
3.73 | gc/mL |
0.0 |
1.36 |
38 |
76 |
26 |
-373.5 |
lavezzo2020suppression
E_symptom
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
4.38 | gc/mL |
0.73 |
0.87 |
46 |
92 |
28 |
352.7 |
lescure2020clinical
naso_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
7.71 | gc/swab |
0.72 |
2.0 |
4 |
34 |
11 |
71.3 |
li2018faecal
stool_lanzhou_lamb_rotavirus_vaccine_pcr
|
rotavirus vaccine |
stool | vaccination |
exponential |
4.39 | gc/wet gram |
2.0 |
3.0 |
15 |
50 |
22 |
209.1 |
liu2024longitudinal
stool_SARSCoV2_N1
|
SARS-CoV-2 |
stool | confirmation date |
exponential |
6.32 | gc/dry gram |
1.18 |
3.0 |
16 |
69 |
36 |
194.2 |
liu2024longitudinal
stool_SARSCoV2_N1
|
SARS-CoV-2 |
stool | confirmation date |
gamma |
5.74 | gc/dry gram |
0.83 |
3.0 |
15 |
67 |
35 |
194.7 |
lucini2026dose
serum_a
|
adenovirus |
serum | treatment |
exponential |
5.77 | gc/mL |
0.36 |
4.44 |
5 |
22 |
7 |
35.9 |
lucini2026dose
serum_b
|
adenovirus |
serum | treatment |
exponential |
5.1 | gc/mL |
0.42 |
2.69 |
6 |
28 |
11 |
44.6 |
lucini2026dose
serum_c
|
adenovirus |
serum | treatment |
exponential |
4.97 | gc/mL |
0.45 |
1.97 |
10 |
42 |
1 |
93.9 |
lucini2026dose
serum_f
|
adenovirus |
serum | treatment |
exponential |
4.21 | gc/mL |
0.28 |
3.28 |
4 |
19 |
9 |
24.3 |
lucini2026dose
stool_a
|
adenovirus |
stool | treatment |
exponential |
10.2 | gc/wet gram |
1.0 |
4.32 |
6 |
21 |
3 |
78.2 |
lucini2026dose
stool_b
|
adenovirus |
stool | treatment |
exponential |
6.72 | gc/wet gram |
0.79 |
4.47 |
4 |
18 |
5 |
48.8 |
lucini2026dose
stool_c
|
adenovirus |
stool | treatment |
exponential |
8.99 | gc/wet gram |
0.79 |
3.0 |
10 |
49 |
0 |
157.5 |
lucini2026dose
stool_c
|
adenovirus |
stool | treatment |
gamma |
7.91 | gc/wet gram |
0.6 |
3.0 |
9 |
39 |
0 |
127.1 |
lucini2026dose
stool_f
|
adenovirus |
stool | treatment |
exponential |
10.89 | gc/wet gram |
0.86 |
3.0 |
7 |
39 |
21 |
83.0 |
ludwig2008quantitative
stool_norovirus_viral_load
|
norovirus |
stool | symptom onset |
exponential |
9.14 | gc/wet gram |
0.86 |
3.51 |
9 |
80 |
0 |
241.7 |
lui2020viral
2019-nCoV_N1
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
5.48 | gc/mL |
0.4 |
2.84 |
9 |
41 |
20 |
72.4 |
lui2020viral
2019-nCoV_N1
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.56 | gc/mL |
0.4 |
2.84 |
8 |
39 |
19 |
82.7 |
martin2010frequent
nasal_hbov_viral_load
|
bocavirus |
nasopharyngeal_swab | enrollment |
exponential |
4.91 | gc/mL |
1.54 |
4.0 |
8 |
69 |
40 |
182.0 |
mijatovicrustempasic2017shedding
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
exponential |
5.66 | gc/mL |
1.73 |
2.07 |
30 |
265 |
111 |
818.5 |
mijatovicrustempasic2017shedding
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
gamma |
5.59 | gc/mL |
1.5 |
2.07 |
29 |
263 |
110 |
809.3 |
mijatovicrustempasic2017shedding
stool_pcv1_dna
|
PCV-1 |
stool | vaccination |
exponential |
4.19 | gc/mL |
0.77 |
2.17 |
23 |
201 |
160 |
228.2 |
miyoshi2015long
stool_norovirus
|
norovirus |
stool | symptom onset |
exponential |
7.47 | gc/wet gram |
0.81 |
3.62 |
4 |
37 |
4 |
101.4 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.92 | gc/mL |
0.34 |
3.0 |
52 |
312 |
199 |
354.0 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma |
3.63 | gc/mL |
0.26 |
3.0 |
42 |
272 |
182 |
295.9 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
3.83 | gc/mL |
0.23 |
3.0 |
45 |
296 |
196 |
382.0 |
natarajan2022gastrointestinal
E-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.9 | gc/mL |
0.46 |
3.0 |
54 |
358 |
202 |
488.0 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.92 | gc/mL |
0.33 |
3.0 |
32 |
194 |
124 |
218.4 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.75 | gc/mL |
0.28 |
3.0 |
45 |
306 |
182 |
273.2 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
gamma |
4.77 | gc/mL |
0.17 |
3.0 |
37 |
268 |
164 |
166.8 |
natarajan2022gastrointestinal
RdRP-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
4.54 | gc/mL |
0.16 |
3.0 |
40 |
296 |
182 |
251.3 |
natarajan2022gastrointestinal
N1-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.25 | gc/mL |
0.5 |
3.0 |
71 |
392 |
174 |
756.2 |
natarajan2022gastrointestinal
N1-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.86 | gc/mL |
0.42 |
3.0 |
76 |
476 |
244 |
683.3 |
natarajan2022gastrointestinal
N2-gRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.86 | gc/mL |
0.33 |
3.0 |
62 |
344 |
178 |
400.6 |
natarajan2022gastrointestinal
N2-gRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.62 | gc/mL |
0.41 |
3.0 |
57 |
372 |
192 |
477.4 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.16 | gc/mL |
0.55 |
3.0 |
63 |
209 |
99 |
470.7 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
3.42 | gc/mL |
0.53 |
3.0 |
29 |
127 |
65 |
347.7 |
natarajan2022gastrointestinal
N1-gRNA-ddPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.49 | gc/mL |
0.48 |
3.0 |
68 |
235 |
91 |
500.6 |
natarajan2022gastrointestinal
E-gRNA-ddPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
3.05 | gc/mL |
0.44 |
3.0 |
18 |
41 |
16 |
111.8 |
natarajan2022gastrointestinal
E-gRNA-ddPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
5.24 | gc/mL |
0.36 |
3.0 |
16 |
35 |
3 |
93.1 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
exponential |
4.2 | gc/mL |
1.14 |
3.0 |
20 |
124 |
85 |
234.0 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma |
5.48 | gc/mL |
1.19 |
3.0 |
15 |
102 |
74 |
201.5 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-OG
|
SARS-CoV-2 |
stool | enrollment |
gamma shifted |
5.06 | gc/mL |
1.12 |
3.0 |
17 |
117 |
84 |
259.2 |
natarajan2022gastrointestinal
N1-sgRNA-RT-qPCR-ZY
|
SARS-CoV-2 |
stool | enrollment |
exponential |
5.58 | gc/mL |
1.35 |
3.0 |
42 |
214 |
111 |
562.4 |
newman2016norovirus
gec_g
|
norovirus |
stool | inoculation |
exponential |
5.48 | gc/wet gram |
2.6 |
3.55 |
25 |
263 |
104 |
1010.3 |
newman2016norovirus
gec_g
|
norovirus |
stool | inoculation |
gamma |
7.07 | gc/wet gram |
1.59 |
3.55 |
25 |
238 |
79 |
817.6 |
peiris2003clinical
NPS_SARS
|
SARS-CoV-1 |
nasopharyngeal_swab | symptom onset |
exponential |
6.92 | gc/mL |
1.15 |
2.98 |
14 |
42 |
0 |
188.8 |
peiris2003clinical
NPS_SARS
|
SARS-CoV-1 |
nasopharyngeal_swab | symptom onset |
gamma |
7.19 | gc/mL |
0.82 |
2.98 |
14 |
42 |
0 |
188.8 |
pereira2022standardization
respiratory_influenzaA_viral_load
|
influenza |
nasopharyngeal_aspirate+nasopharyngeal_swab | symptom onset |
exponential |
6.25 | gc/reaction |
0.18 |
1.31 |
19 |
38 |
3 |
57.3 |
piccirilli2023respiratory
nasopharyngeal_aspirate_RSV_viral_load
|
RSV |
nasopharyngeal_aspirate | hospital admission |
exponential |
4.73 | gc/ng hDNA |
0.45 |
1.68 |
36 |
118 |
13 |
285.6 |
piralla2013different
nasopharyngeal_swab
|
influenza |
nasopharyngeal_swab | confirmation date |
exponential |
6.2 | gc/mL |
0.61 |
2.44 |
44 |
115 |
30 |
347.2 |
piralla2013different
bronchoalveolar_lavage_fluid
|
influenza |
bronchoalveolar_lavage_fluid | confirmation date |
exponential |
7.21 | gc/mL |
0.64 |
1.64 |
4 |
12 |
2 |
39.6 |
rodrigues2020influenza
respiratory_influenza_viral_load
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | treatment |
exponential |
7.09 | gc/mL |
0.86 |
2.09 |
10 |
33 |
7 |
112.9 |
rouphael2025effective
buccal_gc_ml
|
influenza |
buccal_swab | inoculation |
exponential |
2.75 | gc/mL |
1.19 |
2.7 |
5 |
35 |
28 |
64.3 |
rouphael2025effective
oropharyngeal_gc_ml
|
influenza |
oropharyngeal_swab | inoculation |
exponential |
3.09 | gc/mL |
1.85 |
2.7 |
7 |
49 |
24 |
161.5 |
rouphael2025effective
saliva_gc_ml
|
influenza |
saliva | inoculation |
exponential |
3.33 | gc/mL |
1.87 |
2.7 |
8 |
56 |
29 |
170.6 |
rouphael2025effective
anterior_nasal_pfu_ml
|
influenza |
anterior_nares_swab | inoculation |
exponential |
3.38 | pfu/mL |
2.3 |
0.7 |
5 |
35 |
15 |
132.8 |
rouphael2025effective
buccal_pfu_ml
|
influenza |
buccal_swab | inoculation |
exponential |
0.66 | pfu/mL |
0.79 |
0.7 |
3 |
21 |
17 |
35.0 |
rouphael2025effective
saliva_pfu_ml
|
influenza |
saliva | inoculation |
exponential |
2.61 | pfu/mL |
2.09 |
0.7 |
5 |
35 |
17 |
121.2 |
sarasini2006detection
nasopharyngeal_aspirate_metapneumovirus_rna_gc_ml
|
metapneumovirus |
nasopharyngeal_aspirate | confirmation date |
exponential |
8.01 | gc/mL |
0.42 |
3.39 |
5 |
12 |
2 |
34.3 |
schumer2026viral
gc_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
exponential |
6.04 | gc/mL |
1.81 |
2.8 |
25 |
476 |
0 |
2015.9 |
schumer2026viral
gc_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
gamma |
5.9 | gc/mL |
1.22 |
2.8 |
25 |
476 |
0 |
1695.7 |
schumer2026viral
pfu_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
exponential |
3.45 | pfu/mL |
1.55 |
2.0 |
25 |
419 |
0 |
1657.5 |
schumer2026viral
pfu_ml
|
RSV |
nasopharyngeal_aspirate | inoculation |
gamma |
2.97 | pfu/mL |
1.3 |
2.0 |
25 |
419 |
0 |
1559.6 |
shetty2024influenza
nasopharyngeal_swab_pfu_ml
|
influenza |
nasopharyngeal_swab | inoculation |
exponential |
3.53 | pfu/mL |
1.75 |
1.23 |
5 |
30 |
13 |
102.9 |
shetty2024influenza
saliva_pfu_ml
|
influenza |
saliva | inoculation |
exponential |
3.18 | pfu/mL |
2.03 |
0.7 |
5 |
30 |
22 |
72.6 |
suner2023viral
blood
|
mpox |
blood | symptom onset |
exponential |
6.29 | gc/mL |
0.6 |
4.0 |
25 |
125 |
89 |
206.6 |
suner2023viral
pharynx
|
mpox |
oropharyngeal_swab | symptom onset |
exponential |
7.0 | gc/mL |
0.82 |
2.9 |
65 |
356 |
218 |
672.3 |
suner2023viral
rectum
|
mpox |
rectal_swab | symptom onset |
exponential |
7.11 | gc/mL |
0.52 |
2.9 |
55 |
188 |
117 |
349.8 |
suner2023viral
semen
|
mpox |
semen | symptom onset |
exponential |
6.24 | gc/mL |
0.45 |
2.9 |
40 |
128 |
71 |
249.5 |
suner2023viral
semen
|
mpox |
semen | symptom onset |
gamma |
6.21 | gc/mL |
0.25 |
2.9 |
31 |
110 |
64 |
203.7 |
suner2023viral
lesion
|
mpox |
skin_lesion | symptom onset |
exponential |
8.82 | gc/mL |
0.76 |
2.9 |
75 |
364 |
151 |
858.6 |
teunis2015shedding
stool_norovirus_concentration_symptomatic
|
norovirus |
stool | symptom onset |
exponential |
7.97 | gc/wet gram |
0.31 |
3.18 |
61 |
152 |
43 |
318.0 |
teunis2015shedding
stool_norovirus_concentration_asymptomatic
|
norovirus |
stool | confirmation date |
exponential |
6.48 | gc/wet gram |
0.53 |
3.59 |
25 |
57 |
18 |
168.3 |
tjon2006high
stool_hepatitis_A_virus
|
hepatitis A virus |
stool | symptom onset |
exponential |
7.77 | gc/mL |
0.66 |
2.0 |
3 |
23 |
10 |
40.3 |
tsang2016individual
NPSOPS
|
influenza |
nasopharyngeal_swab+oropharyngeal_swab | symptom onset |
exponential |
7.23 | gc/mL |
0.52 |
2.95 |
455 |
1131 |
0 |
3534.6 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
8.05 | gc/mL |
1.02 |
3.26 |
5 |
39 |
2 |
132.2 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
7.65 | gc/mL |
1.01 |
3.26 |
5 |
37 |
2 |
135.2 |
vetter2020daily
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma shifted |
8.11 | gc/mL |
0.94 |
3.26 |
5 |
39 |
2 |
144.1 |
vetter2020daily
OPS_SARSCoV2
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
7.66 | gc/mL |
0.94 |
2.37 |
5 |
35 |
1 |
116.4 |
walsh2013viral
pfu_ml
|
RSV |
anterior_nares_swab+sputum | symptom onset |
exponential |
4.85 | pfu/mL |
0.82 |
0.17 |
22 |
120 |
15 |
369.4 |
walsh2013viral
pfu_ml
|
RSV |
anterior_nares_swab+sputum | symptom onset |
gamma |
2.96 | pfu/mL |
0.72 |
0.17 |
22 |
120 |
15 |
381.3 |
woelfel2020virological
stool
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
6.36 | gc/mL |
0.78 |
2.0 |
8 |
79 |
10 |
212.4 |
woelfel2020virological
stool
|
SARS-CoV-2 |
stool | symptom onset |
gamma |
4.9 | gc/mL |
0.77 |
2.0 |
8 |
79 |
10 |
223.8 |
woelfel2020virological
sputum
|
SARS-CoV-2 |
sputum | symptom onset |
exponential |
7.98 | gc/mL |
1.1 |
2.0 |
9 |
147 |
24 |
434.3 |
woelfel2020virological
oropharyngeal_swab
|
SARS-CoV-2 |
oropharyngeal_swab | symptom onset |
exponential |
6.51 | gc/swab |
1.05 |
2.0 |
9 |
153 |
57 |
342.4 |
xu2020characteristics
rectal_swab_SARSCoV2
|
SARS-CoV-2 |
rectal_swab | hospital admission |
exponential |
6.2 | gc/mL |
1.01 |
2.49 |
7 |
63 |
8 |
201.6 |
xu2020characteristics
rectal_swab_SARSCoV2
|
SARS-CoV-2 |
rectal_swab | hospital admission |
gamma shifted |
5.75 | gc/mL |
0.78 |
2.49 |
7 |
62 |
7 |
196.6 |
xu2020characteristics
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab | hospital admission |
exponential |
5.08 | gc/mL |
0.47 |
2.49 |
7 |
44 |
29 |
54.4 |
yen2011detection
stool_rotavirus_vaccine
|
rotavirus vaccine |
stool | vaccination |
exponential |
11.83 | gc/wet gram |
0.7 |
7.64 |
19 |
54 |
1 |
193.5 |
young2020epidemiologic
swab_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
exponential |
5.42 | gc/swab |
1.08 |
2.02 |
18 |
216 |
65 |
607.0 |
young2020epidemiologic
swab_SARSCoV2_N
|
SARS-CoV-2 |
nasopharyngeal_swab | symptom onset |
gamma |
5.05 | gc/swab |
1.01 |
2.02 |
18 |
216 |
65 |
613.0 |
zhang2021adenovirus
serum_adenovirus_viral_load
|
adenovirus |
serum | confirmation date |
exponential |
5.04 | gc/mL |
0.45 |
2.7 |
7 |
17 |
4 |
48.1 |
zuo2020alterations
stool_SARSCoV2_SymptomOnset
|
SARS-CoV-2 |
stool | symptom onset |
exponential |
6.72 | gc/mL |
0.9 |
2.54 |
9 |
31 |
13 |
92.2 |
akiyama2024efficacy
ct_oropharyngeal_swab
|
mpox |
oropharyngeal_swab |
enrollment |
exponential |
7.34 |
cycles below 40 |
2.41 |
-1.67 |
14 |
95 |
66 |
215.3 |
akiyama2024efficacy
ct_oropharyngeal_swab
|
mpox |
oropharyngeal_swab |
enrollment |
gamma |
1.65 |
cycles below 40 |
2.33 |
-1.67 |
10 |
54 |
36 |
159.9 |
akiyama2024efficacy
ct_urine
|
mpox |
urine |
enrollment |
exponential |
5.9 |
cycles below 40 |
3.8 |
-1.56 |
10 |
74 |
47 |
220.9 |
akiyama2024efficacy
ct_lesion
|
mpox |
skin_lesion |
enrollment |
exponential |
17.77 |
cycles below 40 |
4.13 |
-0.05 |
18 |
94 |
30 |
454.2 |
alsharrah2020clinical
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
14.1 |
cycles below 40 |
4.26 |
-1.0 |
11 |
43 |
22 |
184.6 |
brosius2023presymptomatic
genital_swab
|
mpox |
genital_swab |
exposure |
exponential |
4.74 |
cycles below 40 |
2.27 |
3.0 |
7 |
71 |
54 |
134.0 |
brosius2023presymptomatic
genital_swab
|
mpox |
genital_swab |
exposure |
gamma |
4.22 |
cycles below 40 |
2.18 |
3.0 |
7 |
71 |
54 |
145.8 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
exponential |
19.95 |
cycles below 40 |
4.18 |
3.0 |
78 |
1278 |
596 |
4461.1 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
gamma |
18.2 |
cycles below 40 |
3.79 |
3.0 |
75 |
1235 |
589 |
4234.9 |
cdc2024nhphrn
NP_SARSCoV2_CT
|
SARS-CoV-2 |
nasopharyngeal_swab |
confirmation date |
gamma shifted |
18.73 |
cycles below 40 |
3.76 |
3.0 |
75 |
1265 |
589 |
4532.1 |
chen2024clinical
oropharyngeal_swab
|
mpox |
oropharyngeal_swab |
symptom onset |
exponential |
14.84 |
cycles below 40 |
3.14 |
5.0 |
13 |
58 |
32 |
204.3 |
chen2024clinical
vesicle_swab
|
mpox |
vesicle_swab |
symptom onset |
exponential |
20.07 |
cycles below 40 |
3.97 |
5.0 |
14 |
60 |
23 |
282.5 |
chen2024clinical
urethra_swab
|
mpox |
urethral_swab |
symptom onset |
exponential |
12.83 |
cycles below 40 |
2.48 |
5.0 |
9 |
42 |
18 |
160.7 |
chen2024clinical
urethra_swab
|
mpox |
urethral_swab |
symptom onset |
gamma |
13.96 |
cycles below 40 |
2.42 |
5.0 |
9 |
42 |
18 |
177.7 |
chen2024clinical
rectal_swab
|
mpox |
rectal_swab |
symptom onset |
exponential |
12.87 |
cycles below 40 |
3.93 |
5.0 |
14 |
61 |
32 |
238.6 |
coppee2023temporal
nasopharyngeal_swab_RSV_ct_symptomatic
|
RSV |
nasopharyngeal_swab |
symptom onset |
exponential |
21.48 |
cycles below 40 |
3.37 |
0.0 |
6 |
24 |
4 |
135.2 |
covid2020clinical
Stool_SARSCoV2
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
9.85 |
cycles below 40 |
1.79 |
0.0 |
7 |
34 |
13 |
122.9 |
covid2020clinical
OPS_SARSCoV2
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
9.98 |
cycles below 40 |
3.64 |
0.0 |
11 |
100 |
63 |
274.3 |
covid2020clinical
NPS_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
10.18 |
cycles below 40 |
5.25 |
0.0 |
12 |
106 |
58 |
383.3 |
gaspari2023monkeypox
skin_lesion_swab
|
mpox |
skin_lesion |
symptom onset |
exponential |
23.88 |
cycles below 40 |
0.01 |
1.99 |
6 |
12 |
3 |
-45.7 |
gaspari2023monkeypox
plasma
|
mpox |
plasma |
symptom onset |
exponential |
9.1 |
cycles below 40 |
0.0 |
5.99 |
5 |
10 |
5 |
-68.8 |
gautret2020hydroxychloroquine
nasopharyngeal_swab_SARSCoV2_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
20.97 |
cycles below 40 |
3.27 |
5.0 |
19 |
126 |
44 |
530.4 |
hiramatsu2018rotavirus
rv5_1
|
rotavirus vaccine |
stool |
vaccination |
gamma |
12.49 |
cycles below 40 |
1.63 |
3.03 |
9 |
72 |
3 |
325.1 |
hiramatsu2018rotavirus
rv5_1
|
rotavirus vaccine |
stool |
vaccination |
gamma shifted |
12.43 |
cycles below 40 |
2.4 |
-4.27 |
9 |
73 |
3 |
404.0 |
kimse2020viral
oropharyngealswab_SARSCoV2_symptomatic
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
14.09 |
cycles below 40 |
3.49 |
0.0 |
3 |
21 |
5 |
106.8 |
kimse2020viral
oropharyngealswab_SARSCoV2_asymptomatic
|
SARS-CoV-2 |
oropharyngeal_swab |
confirmation date |
exponential |
7.3 |
cycles below 40 |
2.66 |
0.0 |
8 |
37 |
15 |
155.1 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
exponential |
3.63 |
cycles below 40 |
8.49 |
0.0 |
65 |
2402 |
1679 |
6633.6 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma |
10.07 |
cycles below 40 |
4.21 |
0.0 |
65 |
1983 |
1351 |
4565.3 |
kissler2021densely
AN_OPS_SARSCoV2
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma shifted |
10.12 |
cycles below 40 |
4.44 |
0.0 |
65 |
2074 |
1351 |
5304.8 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
exponential |
4.76 |
cycles below 40 |
6.36 |
0.0 |
67 |
2173 |
1948 |
2123.4 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma |
8.84 |
cycles below 40 |
2.79 |
0.0 |
51 |
1679 |
1525 |
1203.4 |
kissler2021viral
AN_OPS_SARSCoV2_ct
|
SARS-CoV-2 |
anterior_nares_swab+oropharyngeal_swab |
confirmation date |
gamma shifted |
8.63 |
cycles below 40 |
2.87 |
0.0 |
60 |
2072 |
1858 |
1686.6 |
kutter2021small
rsv_nasopharyngeal_aspirate_ct
|
RSV |
nasopharyngeal_aspirate |
symptom onset |
exponential |
19.38 |
cycles below 40 |
2.93 |
0.0 |
6 |
27 |
0 |
160.6 |
limonta2024mpox
pharynx
|
mpox |
oropharyngeal_swab |
enrollment |
exponential |
15.04 |
cycles below 40 |
2.69 |
4.99 |
10 |
28 |
9 |
136.4 |
limonta2024mpox
skin
|
mpox |
skin_lesion |
enrollment |
exponential |
22.34 |
cycles below 40 |
0.0 |
4.99 |
10 |
23 |
10 |
-158.0 |
moschese2022isolation
anorectal_swab
|
mpox |
anorectal_swab |
symptom onset |
exponential |
15.31 |
cycles below 40 |
2.39 |
1.99 |
18 |
46 |
18 |
207.1 |
moschese2022isolation
urethral_swab
|
mpox |
urethral_swab |
symptom onset |
exponential |
11.84 |
cycles below 40 |
2.26 |
2.99 |
17 |
41 |
14 |
194.7 |
moschese2022isolation
urethral_swab
|
mpox |
urethral_swab |
symptom onset |
gamma |
16.34 |
cycles below 40 |
2.26 |
2.99 |
7 |
21 |
6 |
114.4 |
pace2024prevalence
stool_SARSCoV2
|
SARS-CoV-2 |
stool |
enrollment |
exponential |
8.87 |
cycles below 40 |
3.66 |
0.0 |
20 |
119 |
63 |
426.0 |
pace2024prevalence
stool_SARSCoV2
|
SARS-CoV-2 |
stool |
enrollment |
gamma |
8.92 |
cycles below 40 |
2.84 |
0.0 |
20 |
119 |
63 |
432.7 |
peiromestres2022frequent
ct_rectal_swab
|
mpox |
rectal_swab |
symptom onset |
exponential |
19.34 |
cycles below 40 |
1.22 |
5.59 |
9 |
23 |
0 |
112.4 |
peiromestres2022frequent
ct_saliva
|
mpox |
saliva |
symptom onset |
exponential |
12.82 |
cycles below 40 |
0.97 |
2.09 |
9 |
19 |
3 |
85.5 |
peiromestres2022frequent
ct_semen
|
mpox |
semen |
symptom onset |
exponential |
9.72 |
cycles below 40 |
0.66 |
-0.01 |
7 |
14 |
2 |
54.3 |
peiromestres2022frequent
ct_urine
|
mpox |
urine |
symptom onset |
exponential |
8.01 |
cycles below 40 |
3.02 |
-0.01 |
8 |
17 |
5 |
98.1 |
pesonel2025clinical
oropharyngeal_swab
|
mpox |
oropharyngeal_swab |
symptom onset |
exponential |
12.96 |
cycles below 40 |
3.97 |
0.0 |
37 |
122 |
28 |
709.7 |
pesonel2025clinical
anorectal_swab
|
mpox |
anorectal_swab |
symptom onset |
exponential |
21.44 |
cycles below 40 |
2.98 |
0.0 |
20 |
74 |
23 |
348.7 |
pesonel2025clinical
skin
|
mpox |
skin_lesion |
symptom onset |
exponential |
18.2 |
cycles below 40 |
3.48 |
0.0 |
46 |
160 |
16 |
972.5 |
pesonel2025clinical
plasma
|
mpox |
plasma |
symptom onset |
exponential |
5.34 |
cycles below 40 |
2.1 |
0.0 |
27 |
93 |
51 |
310.2 |
pietsch2019intrahost
stool_sapovirus_ct
|
sapovirus |
stool |
symptom onset |
exponential |
18.24 |
cycles below 40 |
2.29 |
0.0 |
5 |
42 |
4 |
198.3 |
relhan2023clinical
ct_lesion_fluid
|
mpox |
vesicle_swab |
symptom onset |
exponential |
20.33 |
cycles below 40 |
8.9 |
0.0 |
5 |
19 |
8 |
109.3 |
relhan2023clinical
ct_lesion_fluid
|
mpox |
vesicle_swab |
symptom onset |
gamma |
18.03 |
cycles below 40 |
8.17 |
0.0 |
5 |
19 |
8 |
117.2 |
salvatore2020epidemiological
N1_probe
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
14.7 |
cycles below 40 |
2.8 |
0.0 |
88 |
217 |
64 |
1129.5 |
salvatore2020epidemiological
N1_probe
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
gamma |
14.81 |
cycles below 40 |
2.32 |
0.0 |
22 |
75 |
19 |
396.2 |
salvatore2020epidemiological
N1_probe
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
gamma shifted |
20.15 |
cycles below 40 |
2.55 |
0.0 |
8 |
39 |
3 |
238.2 |
schuurmans2014clinical
nasopharyngeal_swab_influenza_CT
|
influenza |
nasopharyngeal_swab |
symptom onset |
exponential |
11.71 |
cycles below 40 |
2.65 |
-1.76 |
16 |
54 |
0 |
324.5 |
seah2020assessing
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
14.05 |
cycles below 40 |
3.21 |
0.6 |
17 |
134 |
26 |
667.0 |
seah2020assessing
nasopharyngeal_swab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
gamma |
14.08 |
cycles below 40 |
3.11 |
0.6 |
17 |
134 |
26 |
691.7 |
shrestha2020distribution
swab_SARSCoV2_N_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
18.36 |
cycles below 40 |
3.03 |
0.0 |
124 |
422 |
119 |
2121.5 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
exponential |
17.99 |
cycles below 40 |
3.8 |
3.5 |
11 |
81 |
24 |
381.8 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
gamma |
17.86 |
cycles below 40 |
2.79 |
3.5 |
11 |
79 |
23 |
356.2 |
tan2021early
swab_SARSCoV2_N
|
SARS-CoV-2 |
oropharyngeal_swab |
symptom onset |
gamma shifted |
16.8 |
cycles below 40 |
2.57 |
3.5 |
10 |
77 |
21 |
360.5 |
team2020clinical
naso_swab_SARSCoV2_N_Ct
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
8.82 |
cycles below 40 |
6.14 |
-1.0 |
12 |
121 |
73 |
408.9 |
teunis2015shedding
stool_norovirus_ct_symptomatic
|
norovirus |
stool |
symptom onset |
exponential |
18.29 |
cycles below 40 |
1.43 |
0.0 |
61 |
152 |
43 |
648.5 |
teunis2015shedding
stool_norovirus_ct_asymptomatic
|
norovirus |
stool |
confirmation date |
exponential |
15.96 |
cycles below 40 |
2.51 |
0.0 |
25 |
57 |
18 |
290.3 |
wang2020fecal
stool_SARSCoV2_ORF1ab
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
12.47 |
cycles below 40 |
2.81 |
0.0 |
11 |
56 |
13 |
272.4 |
wang2020fecal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
13.75 |
cycles below 40 |
2.37 |
0.0 |
11 |
56 |
12 |
264.5 |
wang2020fecal
stool_SARSCoV2_N
|
SARS-CoV-2 |
stool |
symptom onset |
gamma |
12.68 |
cycles below 40 |
2.4 |
0.0 |
10 |
54 |
11 |
276.8 |
yang2020laboratory
upper_resp_tract
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab+sputum |
symptom onset |
exponential |
7.1 |
cycles below 40 |
5.5 |
2.0 |
25 |
248 |
146 |
857.2 |
yang2020laboratory
upper_resp_tract
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab+sputum |
symptom onset |
gamma |
7.27 |
cycles below 40 |
5.35 |
2.0 |
25 |
248 |
146 |
900.5 |
yang2020laboratory
lower_resp_tract
|
SARS-CoV-2 |
bronchoalveolar_lavage_fluid |
symptom onset |
exponential |
16.33 |
cycles below 40 |
3.32 |
2.0 |
13 |
76 |
19 |
375.9 |
yilmaz2020upper
oropharyngealswab_SARSCoV2
|
SARS-CoV-2 |
nasopharyngeal_swab+oropharyngeal_swab |
symptom onset |
exponential |
18.26 |
cycles below 40 |
3.72 |
0.0 |
54 |
349 |
80 |
1772.3 |
yuan2021sars
nasopharyngeal_swab_SARSCoV2_ORF1ab_symptomatic
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
9.28 |
cycles below 40 |
7.44 |
0.0 |
6 |
84 |
56 |
261.6 |
yuan2021sars
nasopharyngeal_swab_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
nasopharyngeal_swab |
symptom onset |
exponential |
6.06 |
cycles below 40 |
6.95 |
0.0 |
6 |
84 |
52 |
285.2 |
yuan2021sars
stool_SARSCoV2_ORF1ab_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
9.85 |
cycles below 40 |
4.35 |
0.0 |
3 |
31 |
9 |
152.1 |
yuan2021sars
stool_SARSCoV2_ORF1ab_asymptomatic
|
SARS-CoV-2 |
stool |
confirmation date |
exponential |
11.19 |
cycles below 40 |
2.54 |
0.0 |
3 |
29 |
1 |
148.8 |
yuan2021sars
stool_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
exponential |
8.3 |
cycles below 40 |
5.13 |
0.0 |
5 |
43 |
19 |
179.1 |
yuan2021sars
stool_SARSCoV2_N_symptomatic
|
SARS-CoV-2 |
stool |
symptom onset |
gamma |
6.87 |
cycles below 40 |
4.95 |
0.0 |
5 |
43 |
19 |
191.5 |
yuan2021sars
stool_SARSCoV2_N_asymptomatic
|
SARS-CoV-2 |
stool |
confirmation date |
exponential |
10.65 |
cycles below 40 |
2.53 |
0.0 |
3 |
29 |
1 |
148.3 |